Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_assertion type Assertion NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_head.
- NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_assertion description "[High GCNs of MET and HGF associate with an increased risk of trastuzumab-based therapy failure in HER2-positive MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_provenance.
- NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_assertion evidence source_evidence_literature NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_provenance.
- NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_assertion SIO_000772 22850551 NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_provenance.
- NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_assertion wasDerivedFrom befree-20140225 NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_provenance.
- NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_assertion wasGeneratedBy ECO_0000203 NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_provenance.